STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells

Blood

Volumn 94, Issue 3, 1999, Pages 1108-1112

  De Groot, Rolf P ^a   Raaijmakers, Jan A M ^b   Lammers, Jan Willem J ^b   Jove, Richard ^b   Koenderman, Leo ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN;

ARTICLE; BINDING SITE; CELL STRAIN K 562; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0033178667     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.1108.415k07_1108_1112     Document Type: Article

References (43)

1. Schindler C, Damell JEJ: Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem 64:621, 1995
2. Darnell JE: STATs and gene regulation. Science 277:1630, 1997
3. Liu KD, Gaffen SL, Goldsmith MA: JAK/STAT signaling by cytokine receptors. Curr Opin Immunol 10:271, 1998
4. Horvath CM, Darnell JE: The state of the STATs: Recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol 9:233, 1997
5. Damell JE, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415, 1994
6. Garcia R, Jove R: Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci 5:79, 1998
7. Danial NN, Perni's A, Rothman PB: Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875, 1995
8. Chai SK, Nichols GL, Rothman P: Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. J Immunol 159:4720, 1997
9. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL: Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247, 1996
10. Ahmed M, Dusanter-Fourt I, Bernard M, Mayeux P, Hawley RG, Bennardo T, Novault S, Bonnet ML, Gisselbrecht S, Varet B, Turhan AG: BCR-ABL and constitutively active erythropoietin receptor (cE-poR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line. Oncogene 16:489, 1998
11. Ilaria RL, Van Etten RA: P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 271:31704, 1996
12. Frank DA, Varticovski L: BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia 10:1724, 1996
13. Carlesso N, Frank DA, Griffin JD: Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811, 1996
14. Danial NN, Pernis A, Rothman PB: Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875, 1995
15. Vincenti MP, Schroen DJ, Coon CI, Brinckerhoff CE: v-src activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: Requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors. Mol Carcinog 21:194, 1998
16. Smith PD, Crompton MR: Expression of v-src in mammary epithelial cells induces transcription via STAT3. Biochem J 331:381, 1998
17. Yu CL, Meyer DJ, Campbell GS, Lamer AC, Carter-Su C, Schwartz J, Jove R: Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81, 1995
18. Bromberg JF, Horvath CM, Besser D, Lathem WW, Damell JE: Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18:2553, 1998
19. Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R: Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 8:1267, 1997
20. Cao X, Tay A, Guy GR, Tan YH: Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595, 1996
21. Chaturvedi P, Sharma S, Reddy EP: Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol Cell Biol 17:3295, 1997
22. Turkson J, Bowman T, Garcia R, Caldenhoven E, de Groot RP, Jove R: Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18:2545, 1998
23. Zong C, Yan R, August A, Darnell JE, Hanafusa H: Unique signal transduction of Eyk: Constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J 15:4515, 1996
24. Watson CJ, Miller WR: Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer 71:840, 1995
25. Sartor CI, Dziubinski ML, Yu CL, Jove R, Ethier SP: Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 57:978, 1997
26. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ: Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79, 1995
27. Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, Yamaguchi K, Takatsuki K, Kaminira S, White JD, Leonard WJ, Waldmann T, Franchini G: Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 94:13897, 1997
28. Yu CL, Jove R, Burakoff SJ: Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J Immunol 159:5206, 1997
29. Weber Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux Gruart V, Mertelsmann R, Finke J: Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809, 1996
30. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining (letter). Nature 243:290, 1973
31. Daley GQ, Baltimore D: Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci USA 85: 9312, 1988
32. Daley GQ, McLaughlin J, Witte ON, Baltimore D: The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 237:532, 1987
33. Sattler M, Salgia R: Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine Growth Factor Rev 8:63, 1997
34. de Groot RP, Coffer P, Koenderman L: Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal 8:12, 1998
35. Mui ALF, Wakao H, Kinoshita T, Kitamura T, Miyajima A: Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation. EMBO J 15:2425, 1996
36. Onishi M, Nosaka T, Misawa K, Mui AF, Gorman D, McMahon M, Miyajima A, Kitamura T: Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18:3871, 1998
37. Moriggl R, Gouilleux Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F: Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 16:5691, 1996
38. Caldenhoven E, Vandijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L, Degroot RP: STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271:13221, 1996
39. Caldenhoven E, van Dijk T, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP: Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J Biol Chem 270:25778, 1995
40. de Groot RP, Kruyt FA, van der Saag PT, Kruijer W: Ectopic expression of c-jun leads to differentiation of P19 embryonal carcinoma cells. EMBO J 9:1831, 1990
41. Fried M, Crothers DM: Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res 9:6505, 1981
42. Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ, Hennighausen L, Finbloom DS: STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90:1768, 1997
43. Berchtold S, Moriggl R, Gouilleux F, Silvennoinen O, Beisenherz C, Pfitzner E, Wissler M, Stocklin E, Groner B: Cytokine receptor-independent, constitutively active variants of STAT5. J Biol Chem 272:30237, 1997